secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001104659-24-041160
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics extends credit facility maturity to March 31, 2029
----------------------------------------------------------------------

- Second one-year extension of $1.2B and $800M revolving credit facilities.
- New maturity date March 31, 2029; effective March 29, 2024.
- Facility capacity can be increased by up to $500M aggregate.
- All other terms of the credit agreement remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465924041160/0001104659-24-041160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465924041160/tm249556d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-041160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer